JohnGlodMD

Pediatric Hematology & Oncology • New Brunswick, NJ

Assistant Professor, Pediatrics, UMDNJ-Robert Wood Johnson Medical School

Join to view full profile

Are you Dr. Glod?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 41 invites waiting!
Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

Office
195 Little Albany St
New Brunswick, NJ 08901
Phone+1 732-235-6455

Fax+1 732-235-6462

Summary

Dr. John Glod, MD is a pediatric hematologist/oncologist in New Brunswick, New Jersey. He is currently licensed to practice medicine in New Jersey, Maryland, and Ohio. He is an Assistant Professor at UMDNJ-Robert Wood Johnson Medical School.

Education & Training

Cincinnati Children's Hospital Medical CenterFellowship, Pediatric Hematology/Oncology, 1999 - 2000
Cincinnati Children's Hospital Medical CenterResidency, Pediatrics, 1996 - 1999
University of Colorado School of Medicine Anschutz Medical CampusClass of 1996

Certifications & Licensure

NJ State Medical License 2003 - 2025
MD State Medical License 2002 - 2006
OH State Medical License 1997 - 2001
American Board of Pediatrics Pediatric Hematology-Oncology

Publications & Presentations

PubMed

397 citations
Activity of Selumetinib in Neurofibromatosis Type 1–Related Plexiform Neurofibromas
Eva Dombi, Andrea Baldwin, Leigh Marcus, Michael Fisher, Brian Weiss
The New England Journal of Medicine. 2016-12-28
22 citations
Atezolizumab for Advanced Alveolar Soft Part Sarcoma.
Alice P Chen, Elad Sharon, Geraldine O'Sullivan-Coyne, Nancy Moore, Jared C Foster
The New England Journal of Medicine. 2023-09-07
68 citations
Characterization of folate uptake by choroid plexus epithelial cells in a rat primary culture model.
Jan B. Wollack, Benedette Makori, Stuti Ahlawat, Rajeth Koneru, Sonia C. Picinich
Journal of Neurochemistry. 2008-03-01

Press Mentions

Drug Approved to Help Young Patients Battle a Rare CancerJanuary 2nd, 2023
Slips, Slides: Winter Injuries Can Be SeriousJanuary 2nd, 2023
NCI Clinical Trial Leads to Atezolizumab Approval for Advanced Alveolar Soft Part SarcomaDecember 28th, 2022